It starts with a question:
No matter what name is on the hospital, we’re all working to answer the same questions. The ones we ask with our hearts and answer with our heads.
See how we’re working towards answersMeet the team behind the questions
What Difference Does a Pediatric Proton Therapy Center Make?
If we are effective at replicating what we did in lab, we are looking at a cure for a disease that affects more than 100,000 people in the United States.
Punam Malik, MD on the potential of gene therapy as a sickle cell cure
See Info
John Perentesis, MD, FAAP
Director, Division of Oncology; Institute Co-Director, Cancer and Blood Diseases Institute; Deb Kleisinger Endowed Chair 513-636-8241 john.perentesis@cchmc.orgSee Info
Stella Davies, MBBS, PhD, MRCP
Director, Division of Bone Marrow Transplantation and Immune Deficiency; Institute Co-Director, Cancer and Blood Diseases Institute; Jacob G. Schmidlapp Endowed Chair 513-636-1371 stella.davies@cchmc.orgSee Info
Russell Ware, MD, PhD
Director, Division of Hematology; Institute Co-Director, Cancer and Blood Diseases Institute; Associate Director, Global Health Center; Marjory J. Johnson Chair of Hematology Translational Research 513-517-2344 russell.ware@cchmc.orgHow does Overexpression of TRAF6 Drive the Body’s Immune Response?
What is Happening on the Front Lines of ALL and AML Research?
What is the Connection Between Tumor Sequencing and Relapsed Cancers?
See Info